John J. Warner, MD, Chief Executive Officer of The Ohio State University Wexner Medical Center& Jay Anderson, Chief Operating Officer at The Ohio State University Wexner Medical Center | https://wexnermedical.osu.edu/about-us/our-people
+ Pharmaceuticals
Patient Daily | Nov 26, 2024

Rising whooping cough cases prompt vaccination reminders from CDC

Whooping cough, also known as pertussis, is seeing a resurgence in the United States with cases returning to pre-pandemic levels of over 10,000 annually. The U.S. Centers for Disease Control and Prevention (CDC) has reported this increase.

Early symptoms of whooping cough can resemble those of other viral illnesses such as the flu or COVID-19, starting with a runny nose, low-grade fever, and mild coughing. However, pertussis may lead to severe coughing fits after one or two weeks, often characterized by a "whoop" sound due to difficulty breathing between coughs.

The CDC noted that as of June 1, 2024, reported cases have more than doubled compared to the same period in 2023. This rise highlights the importance of staying up-to-date with vaccinations against pertussis. Adults are advised to receive a booster vaccine every ten years since its effectiveness diminishes over time. The vaccine is administered as part of a combination shot against tetanus and diphtheria (DTaP or Tdap).

Preventing whooping cough involves good hygiene practices like washing hands regularly for at least 20 seconds with soap and water. Infected individuals should stay home and avoid contact with high-risk groups such as infants and those with compromised immune systems.

Treatment for whooping cough includes antibiotics and over-the-counter medications for symptom relief. Rest and hydration are recommended, while severe symptoms might necessitate hospital care.

If you suspect that you or someone you know has contracted whooping cough, it is crucial to contact your primary care provider for evaluation and possible testing for pertussis.

Organizations in this story

More News